Erratum: In vitro effect of valepotriates isolated from valeriana glechomifolia on Rat P-type ATPases (Planta Medica (2011) DOI: 10.1055/s-0030-1271084);In vitro effect of valepotriates isolated from valeriana glechomifolia on rat P-type ATPases

Planta Medica

Volumn 77, Issue 15, 2011, Pages 1702-1706

  Bettero, Gustavo M ^a   Salles, Luisa ^b   Rosário Figueira, Renata M ^a   Poser, Gilsane Von ^b   Rates, Stela M K ^b   Noël, François ^a   Quintas, Luis E M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

ATPase; inhibition; rat; valepotriates; Valeriana glechomifolia; Valerianaceae

Indexed keywords

1 BETA ACEVALTRATE; ACEVALTRATE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; THAPSIGARGIN; UNCLASSIFIED DRUG; VALEPOTRIATE; VALTRATE;

ARTICLE; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; HEMISPHERE; IC 50; IN VITRO STUDY; KIDNEY; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; SKELETAL MUSCLE; STOMACH EPITHELIUM; VALERIANA; VALERIANA GLECHOMIFOLIA; VALERIANACEAE;

RATTUS; VALERIANA; VALERIANA GLECHOMIFOLIA; VALERIANACEAE;

EID: 80054791823     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0031-1280009     Document Type: Erratum

References (37)

1. Yatime L, Buch-Pedersen M J., Musgaard M, Morth J P., Lund Winther A M., Pedersen B P., Olesen C, Andersen J P., Vilsen B, Schitt B, Palmgren M G., Mller J V., Nissen P, Fedosova N. P-type ATPases as drug targets: tools for medicine and science. Biochim Biophys Acta 2009 1787 207-220
2. Axelsen K B., Palmgren M G. Evolution of substrate specificities in the P-type ATPase superfamily. J Mol Evol 1998 46 84-101 (Pubitemid 28047242)
3. Thever M D., Saier Jr. M H. Bioinformatic characterization of P-type ATPases encoded within the fully sequenced genomes of 26 eukaryotes. J Membr Biol 2009 229 115-130
4. +-ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry 2006 60 491-499 (Pubitemid 44292163)
5. Moseley A E., Williams M T., Schaefer T L., Bohanan C S., Neumann J C., Behbehani M M., Vorhees C V., Lingrel J B. Deficiency in Na,K-ATPase isoform genes alters spatial learning, motor activity, and anxiety in mice. J Neurochem 2007 27 616-626 (Pubitemid 46143765)
6. Wink M. Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine. Curr Drug Metab 2008 9 996-1009
7. +-ATPase activity by ()-ent-kaur-16-en-19-oic acid and its derivatives. Planta Med 2003 69 555-556 (Pubitemid 36870633)
8. +-ATPase by diterpenes extracted from the Brazilian brown alga Dictyota cervicornis. Phytother Res 2009 23 943-947
9. 2+-ATPase (SERCA) inhibition. J Bioenerg Biomembr 2005 37 365-368
10. Lin S, Shen Y H., Li H L., Yang X W., Chen T, Lu L H., Huang Z S., Liu R H., Xu X K., Zhang W D., Wang H. Acylated iridoids with cytotoxicity from Valeriana jatamansi. J Nat Prod 2009 72 650-655
11. World Health Organization. WHO monographs on selected medicinal plants. Malta WHO Graphics 1999
12. Salles L A., Silva A L., Rech S B., Zanatta N, von Poser G L. Constituents of Valeriana glechomifolia Meyer. Biochem Syst Ecol 2000 28 907-910
13. Silva A L., Rech S B., von Poser G L. Quantitative determination of valepotriates from Valeriana native to South Brazil. Planta Med 2002 68 570-572 (Pubitemid 34774762)
14. Bos R, Woerdenbag H J., Pras N. Determination of valepotriates. J Chromatogr A 2002 967 131-146 (Pubitemid 34786588)
15. Andreatini R, Leite J R. Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal. Eur J Pharmacol 1994 260 233-235 (Pubitemid 24240026)
16. Maurmann N, Reolon G K., Rech S B., Fett-Neto A G., Roesler R. A valepotriate fraction of Valeriana glechomifolia shows sedative and anxiolytic properties and impairs recognition but not aversive memory in mice. Evid Based Complement Alternat Med advance online publication 2010
17. Bounthanh C, Richert L, Beck J P., Haag-Berrurier M, Anton R. The action of valepotriates on the synthesis of DNA and proteins of cultured hepatoma cells. Planta Med 1983 49 138-142 (Pubitemid 14220762)
18. Bounthanh C, Bergmann C, Beck J P., Haag-Berrurier M, Anton R. Valepotriates, a new class of cytotoxic and antitumor agents. Planta Med 1981 41 21-28 (Pubitemid 11183382)
19. +)-ATPase inhibition in microsomes from rat heart. Biochem Pharmacol 1984 33 47-53 (Pubitemid 14192789)
20. Lowry O H., Rosenbrough N J., Farr A L., Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951 193 265-275
21. 2+ homeostasis in rat vas deferens. J Pharmacol Toxicol Methods 2002 47 93-98 (Pubitemid 35373966)
22. Tomiyama Y, Morii M, Takeguchi N. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently. Biochem Pharmacol 1994 48 2049-2055
23. Fiske C H., Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925 66 375-392
24. +-ATPase density is sexually dimorphic in the adult rat kidney. Ann NY Acad Sci 1997 834 552-554 (Pubitemid 28009123)
25. +-ATPase inhibition by 2-methoxy-3,8,9-trihydroxy coumestan. Bioorg Med Chem 2008 16 8801-8805
26. Andreatini R, Sartori V A., Seabra M L., Leite J R. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res 2002 16 650-654 (Pubitemid 35334186)
27. Mercer R W. Structure of the Na,K-ATPase. Int Rev Cytol 1993 137C 139-168 (Pubitemid 23204716)
28. Sverdlov E D. The genes of Na,K-ATPase, a selfreview. Genetica 1991 85 91-101
29. +-ATPase activity. Mol Pharmacol 1993 44 129-141 (Pubitemid 23230469)
30. +-ATPase activity in synaptic plasma membranes from the cerebral cortex of rats. Braz J Med Biol Res 2001 34 1265-1269 (Pubitemid 33014493)
31. Keochanthala-Bounthanh C, Haag-Berrurier M, Beck J P., Anton R. Effects of thiol compounds versus the cytotoxicity of valepotriates on cultured hepatoma cells. Planta Med 1990 56 190-192 (Pubitemid 20168053)
32. 2+-ATPase: a computational docking study. Proteins 2004 56 595-606 (Pubitemid 38924971)
33. Singh P, Mhaka A M., Christensen S B., Gray J J., Denmeade S R., Isaacs J T. Applying linear interaction energy method for rational design of noncompetitive allosteric inhibitors of the sarco- and endoplasmic reticulum calcium-ATPase. J Med Chem 2005 48 3005-3014 (Pubitemid 40548112)
34. Mller W E., Singer A, Wonnemann M, Hafner U, Rolli M, Schfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 1998 31 (Suppl.1) 16-21
35. +-dependent transport in spinal cord white matter. Neuroscience 2001 107 675-683 (Pubitemid 33097503)
36. Hobbs C. Valerian: a literature review. Herbal Gram 1989 21 19-34
37. +-ATPase with an original mechanism of action. Biochem Pharmacol 2003 66 2169-2176 (Pubitemid 37377861)